Tallinn, Estonia

Tonis Pehk

This inventor holds 1 USPTO granted patent. Top assignees: Cambrex Tallinn as, Tallinn University of Technology. Active years: 2012.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tonis Pehk

Introduction

Tonis Pehk is a notable inventor based in Tallinn, Estonia. He has made significant contributions to the field of chemistry, particularly in the synthesis of homocitric acid gamma-lactone and its corresponding salts. His innovative methods have garnered attention in the scientific community.

Latest Patents

Tonis Pehk holds a patent for a method involving the synthesis of Archiral (2-hydroxy-3-oxo-cyclopent-1-enyl) acetic acid alkyl, alkylphenyl, and phenyl esters. This patent describes a simple and efficient method for producing both enantiomers of homocitric acid gamma-lactone. The process is based on asymmetric oxidation of esters, followed by basic and acidic hydrolysis, culminating in the acidic lactonization of homocitric acid. The resulting homocitric acid salts are obtained through basic treatment of the gamma-lactone. The esters, conditions, and reagents used in this chemical conversion are crucial for the efficient production of homocitric acid gamma-lactone and its salts.

Career Highlights

Throughout his career, Tonis Pehk has worked with prominent organizations such as Cambrex Tallinn and Tallinn University of Technology. His experience in these institutions has allowed him to refine his skills and contribute to various research projects.

Collaborations

Some of Tonis Pehk's notable coworkers include Margus Eek and Anne Paju. Their collaborative efforts have further advanced the research and development in their respective fields.

Conclusion

Tonis Pehk's innovative work in the synthesis of homocitric acid gamma-lactone showcases his expertise and dedication to advancing chemical methodologies. His contributions continue to impact the scientific community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…